Exercise capacity impairment in COPD patients with comorbidities

被引:6
作者
Da Silva, G. P. F. [1 ,3 ]
Pessoa Morano, M. T. A. [2 ]
De Matos Cavalcante, A. G. [1 ]
De Andrade, N. M. [1 ]
De Francesco Daher, E. [1 ]
Pereira, E. D. B. [1 ]
机构
[1] Univ Fed Ceara UFC, Fortaleza, Ceara, Brazil
[2] Hosp Messejana Dr Carlos Alberto Studart Gomes, Fortaleza, Ceara, Brazil
[3] Univ Fortaleza UNIFOR, Fortaleza, Ceara, Brazil
关键词
Exercise capacity; Health status; COPD; Comorbidity; OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; ARTERIAL STIFFNESS; EMPHYSEMA; MORTALITY; ANXIETY; IMPACT; INTERVENTION;
D O I
10.1016/j.rppnen.2015.04.003
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Comorbidities are common in COPD and have been associated with reduced health status, increased health care utilization, all-cause hospitalization, and mortality. There is a scarcity of data on the relationship between comorbidities and functional capacity. Objective: to evaluate the impact of comorbidities on functional capacity of COPD patients. Methods: a cross-sectional study was conducted at two teaching hospitals in Fortaleza, Brazil. The functional capacity was assessed by spirometry and the 6-min walking test (6MWT). The health status was assessed by the St. George's respiratory questionnaire (SGRQ) and the COPD assessment test (CAT). The sample was stratified as having "none", "one" and "two or three'' comorbidities groups. One-way ANOVA was used to compare means of the three groups and a multiple linear regression was run to predict the impact of comorbidities on 6MWT. Results: Comorbidities (hypertension, coronary disease and diabetes) were found in 54% of the studied patients. The mean age of the 79 patients was 67 +/- 8 years and 55% were male. CAT scores increased from "no comorbidity" (17.9 +/- 7.7) to "one comorbidity" (22.8 +/- 6.8) and "two or three comorbidities" groups (24.2 +/- 10.2). A post hoc test showed a significant difference in the "no comorbidity" compared to the "two or three comorbidities" groups (p = 0.01). The distance walked by the patients decreased from "no comorbidity" (386.1 +/- 83.2 m) to "one comorbidity" (350 +/- 98 m) and "two or three comorbidities" groups (312.6 +/- 91 m). A post hoc test showed significant difference in the "no comorbidity" compared to "two or three comorbidities" groups (p = 0.007). Numbers of comorbidities were independently associated with the 6 MWT adjusting for age, severity of COPD and CAT scores. Conclusion: in the studied sample, the presence of comorbidities contributed to impair exercise capacity in patients with COPD. (C) 2014 Sociedade Portuguesa de Pneumologia. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:233 / 238
页数:6
相关论文
共 50 条
  • [31] Molecular and clinical diseasome of comorbidities in exacerbated COPD patients
    Faner, Rosa
    Gutierrez-Sacristan, Alba
    Castro-Acosta, Ady
    Grosdidier, Solene
    Gan, Wenqi
    Sanchez-Mayor, Milagros
    Luis Lopez-Campos, Jose
    Pozo-Rodriguez, Francisco
    Sanz, Ferran
    Mannino, David
    Furlong, Laura I.
    Agusti, Alvar
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (04) : 1001 - 1010
  • [32] Can static hyperinflation predict exercise capacity in COPD?
    Ladeira, I.
    Oliveira, P.
    Gomes, J.
    Lima, R.
    Guimaraes, M.
    PULMONOLOGY, 2023, 29 : S44 - S53
  • [33] Right ventricular diastolic function and exercise capacity in COPD
    Fenster, Brett E.
    Holm, Kristen E.
    Weinberger, Howard D.
    Moreau, Kerrie L.
    Meschede, Kimberly
    Crapo, James D.
    Make, Barry J.
    Bowler, Russell
    Wamboldt, Frederick S.
    Hoth, Karin F.
    RESPIRATORY MEDICINE, 2015, 109 (10) : 1287 - 1292
  • [34] Exercise Performance as a Predictor for Balance Impairment in COPD Patients
    Liwsrisakun, Chalerm
    Pothirat, Chaicharn
    Chaiwong, Warawut
    Bumroongkit, Chaiwat
    Deesomchok, Athavudh
    Theerakittikul, Theerakorn
    Limsukon, Atikun
    Tajarernmuang, Pattraporn
    Phetsuk, Nittaya
    MEDICINA-LITHUANIA, 2019, 55 (05):
  • [35] Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity
    Mandal, Jyotshna
    Roth, Michael
    Papakonstantinou, Eleni
    Tamm, Michael
    Boeck, Lucas
    Scherr, Andreas
    Rakic, Janko
    Louis, Renaud
    Milencovic, Branislava
    Boersma, Wim
    Kostikas, Konstantinos
    Blasi, Francesco
    Aerts, Joachim
    Rohde, Gernot
    Lacoma, Alicia
    Torres, Antoni
    Welte, Tobias
    Stolz, Daiana
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [36] Managing comorbidities in COPD
    Hillas, Georgios
    Perlikos, Fotis
    Tsiligianni, Ioanna
    Tzanakis, Nikolaos
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 95 - 109
  • [37] Associations of Upper-Extremity Exercise Capacity and Grip Strength With Cognitive Domains in Patients With COPD
    Dag, Bedriye
    Naz, Ilknur
    Felekoglu, Elvan
    Emuk, Yusuf
    Kopruluoglu, Melissa
    Sahin, Hulya
    RESPIRATORY CARE, 2024, 69 (05) : 595 - 602
  • [38] Correlations Between Small Airway Function, Ventilation Distribution, and Functional Exercise Capacity in COPD Patients
    Lopes, Agnaldo Jose
    Mafort, Thiago Thomaz
    LUNG, 2014, 192 (05) : 653 - 659
  • [39] Effects of formoterol (Oxis®Turbuhaler®) and ipratropium on exercise capacity in patients with COPD
    Liesker, JJW
    Van de Velde, V
    Meysman, M
    Vincken, W
    Wollmer, P
    Hansson, L
    Kerstjens, HAM
    Qvint, U
    Pauwels, RA
    RESPIRATORY MEDICINE, 2002, 96 (08) : 559 - 566
  • [40] Effects of water-based Liuzijue exercise on peak exercise capacity, functional exercise capacity, and quality of life in people with COPD
    Liu, Xiaodan
    Wu, Weibing
    Li, Ning
    Li, Peijun
    Wang, Zhenwei
    Shan, Chunlei
    CLINICAL RESPIRATORY JOURNAL, 2021, 15 (09) : 956 - 966